Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 Protocol

The COSMYC Trial (COmbined Suppression of MYC)

NCT06922318 ·Status: RECRUITING ·Phase: PHASE2

Use of an Experimental Drug, CC-115, With Enzalutamide in Men With Castration-Resistant Prostate Cancer

NCT02833883 ·Status: COMPLETED ·Phase: PHASE1

Trial Assessing Zactima Against Placebo in Prostate Cancer Subjects Undergoing Intermittent Androgen Deprivation Hormonal Therapy

NCT00686036 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of Enzalutamide in Chemotherapy-Naïve, Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer

NCT01663415 ·Status: WITHDRAWN ·Phase: PHASE2

A Safety and Efficacy Study of SHR3680 in Metastatic Castration-Resistant Prostate Cancer Patients

NCT02691975 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Study of Enzalutamide in Patients With Castration-resistant Prostate Cancer

NCT01942837 ·Status: COMPLETED ·Phase: PHASE2

Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide Resistance

NCT02286921 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide

NCT01977651 ·Status: COMPLETED ·Phase: PHASE4

Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression

NCT04363164 ·Status: RECRUITING ·Phase: PHASE2

A Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate Cancer

NCT00992745 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate Exicorilant (CORT125281) in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer

NCT03437941 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

A Study of Sipuleucel-T With Administration of Enzalutamide in Men With Metastatic Castrate-Resistant Prostate Cancer

NCT01981122 ·Status: COMPLETED ·Phase: PHASE2

Casodex/Zoladex Biomarkers in Localised Prostate Cancer

NCT00293696 ·Status: COMPLETED ·Phase: PHASE4

A Study to Determine Enzalutamide Long-term Safety and Efficacy After Anti-androgen Therapy for CRPC

NCT02669147 ·Status: COMPLETED

HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

NCT03850795 ·Status: TERMINATED ·Phase: PHASE3

Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)

NCT02861573 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Enzalutamide With Venetoclax in Treating Patients With Metastatic Castration Resistant Prostate Cancer

NCT03751436 ·Status: COMPLETED ·Phase: PHASE1

Dose-finding Study of GSK2636771 When Administered in Combination With Enzalutamide in Male Subjects With Metastatic Castration-Resistant Prostate Cancer

NCT02215096 ·Status: COMPLETED ·Phase: PHASE1

The Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting Osteoporosis

NCT00171639 ·Status: COMPLETED ·Phase: PHASE3

Radium Ra 223 With Enzalutamide Compared to Enzalutamide Alone in Men With Metastatic Castration Refractory Prostate Cancer

NCT02199197 ·Status: COMPLETED ·Phase: PHASE2

Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability

NCT02663193 ·Status: COMPLETED

A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

NCT02960022 ·Status: RECRUITING ·Phase: PHASE2

Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer

NCT00887198 ·Status: COMPLETED ·Phase: PHASE3

A Prostate Cancer Study in Men Undergoing Androgen Deprivation Therapy

NCT00087659 ·Status: COMPLETED ·Phase: NA

EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

NCT01360840 ·Status: COMPLETED ·Phase: PHASE2